Back to Journals » Vascular Health and Risk Management » Volume 10

A clinician’s perspective: novel oral anticoagulants to reduce the risk of stroke in nonvalvular atrial fibrillation – full speed ahead or proceed with caution?

Authors Yang E

Received 21 May 2014

Accepted for publication 18 June 2014

Published 21 August 2014 Volume 2014:10 Pages 507—522


Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 3

Eugene Yang

Division of Cardiology, University of Washington Medical Center, Seattle, WA, USA

Abstract: Over the past few years, three novel oral anticoagulants, dabigatran, rivaroxaban, and apixaban, have been approved in the USA and Europe to reduce the risk of stroke or systemic embolism in patients with nonvalvular atrial fibrillation, and the results of a Phase III trial for a fourth novel oral anticoagulant, edoxaban, have recently been published. The aim of this review is to examine this indication from a clinician’s perspective, highlighting efficacy and safety results from the major trials with these novel oral agents. Clinical issues regarding bleeding, monitoring, and reversal are discussed, along with requirements to consider when interrupting treatment with a novel oral anticoagulant for the purpose of transitioning to another anticoagulant and prior to cardioversion, ablation, percutaneous coronary intervention, or emergency surgery. The cost-effectiveness of each of the approved novel oral anticoagulants is reviewed, and the author provides recommendations for selecting appropriate patients for these agents.

Keywords: apixaban, dabigatran, rivaroxaban, edoxaban, anticoagulant reversal, anticoagulant monitoring

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]


Readers of this article also read:

Emerging and future therapies for hemophilia

Carr ME, Tortella BJ

Journal of Blood Medicine 2015, 6:245-255

Published Date: 3 September 2015

Prevention of venous thromboembolism in patients undergoing bariatric surgery

Bartlett MA, Mauck KF, Daniels PR

Vascular Health and Risk Management 2015, 11:461-477

Published Date: 17 August 2015

Response to “Oral health in the elderly patient and its impact on general well-being: a nonsystematic review” paper

Muc-Wierzgoń M, Kokot T, Nowakowska-Zajdel E, Błażelonis A, Fatyga E

Clinical Interventions in Aging 2015, 10:827-828

Published Date: 2 May 2015

A new recombinant factor VIII: from genetics to clinical use

Santagostino E

Drug Design, Development and Therapy 2014, 8:2507-2515

Published Date: 12 December 2014

Caval filters in intensive care: a retrospective study

Ferraro F, Di Gennaro TL, Torino A, Petruzzi J, d'Elia A, Fusco P, Marfella R, Lettieri B

Drug Design, Development and Therapy 2014, 8:2213-2219

Published Date: 6 November 2014

Health claims database study of cyclosporine ophthalmic emulsion treatment patterns in dry eye patients

Stonecipher KG, Chia J, Onyenwenyi A, Villanueva L, Hollander DA

Therapeutics and Clinical Risk Management 2013, 9:409-415

Published Date: 25 October 2013

Acoustic cardiac signals analysis: a Kalman filter–based approach

Salleh SH, Hussain HS, Swee TT, Ting CM, Noor AM, Pipatsart S, Ali J, Yupapin PP

International Journal of Nanomedicine 2012, 7:2873-2881

Published Date: 11 June 2012

Enhanced oral bioavailability of cyclosporine A by liposomes containing a bile salt

Guan P, Lu Y, Qi J, Niu M, Lian R, Hu F, Wu W

International Journal of Nanomedicine 2011, 6:965-974

Published Date: 4 May 2011

Relevance of tumor angiogenesis patterns as a diagnostic value and prognostic indicator in oral precancer and cancer

Devi Charan Shetty, Puneet Ahuja, DK Taneja, et al

Vascular Health and Risk Management 2011, 7:41-47

Published Date: 27 January 2011